ZUMA-8: A phase 1/2 multicenter study evaluating KTE-X19 in patients (pts) with relapsed/refractory (RR) chronic lymph ocytic leukemia (CLL). Flinn, I., Marris, M., Wierda, W. G., Coutre, S., Pagel, J. M., Byrd, J. C., Goyal, L., Goodman, K., Zheng, Y., Milletti, F., Murugappan, S., Brown, J. R. AMER SOC CLINICAL ONCOLOGY. 2019

View details for Web of Science ID 000487345803433